Deficiency of aldose reductase attenuates inner retinal neuronal changes in a mouse model of retinopathy of prematurity.
Retinopathy of prematurity (ROP) is a leading cause of childhood blindness where vascular abnormality and retinal dysfunction are reported. We showed earlier that genetic deletion of aldose reductase (AR), the rate-limiting enzyme in the polyol pathway, reduced the neovascularization through attenuating oxidative stress induction in the mouse oxygen-induced retinopathy (OIR) modeling ROP. In this study, we further investigated the effects of AR deficiency on retinal neurons in the mouse OIR. Seven-day-old wild-type and AR-deficient mice were exposed to 75 % oxygen for 5 days and then returned to room air. Electroretinography was used to assess the neuronal function at postnatal day (P) 30. On P17 and P30, retinal cytoarchitecture was examined by morphometric analysis and immunohistochemistry for calbindin, protein kinase C alpha, calretinin, Tuj1, and glial fibrillary acidic protein. In OIR, attenuated amplitudes and delayed implicit time of a-wave, b-wave, and oscillatory potentials were observed in wild-type mice, but they were not significantly changed in AR-deficient mice. The morphological changes of horizontal, rod bipolar, and amacrine cells were shown in wild-type mice and these changes were partly preserved with AR deficiency. AR deficiency attenuated the Müller cell gliosis induced in OIR. Our observations demonstrated AR deficiency preserved retinal functions in OIR and AR deficiency could partly reduce the extent of retinal neuronal histopathology. These findings suggested a therapeutic potential of AR inhibition in ROP treatment with beneficial effects on the retinal neurons.
Department of Ophthalmology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China.
Zhongjie
Z
Fu
Shen
S
Nian
Suk-Yee
SY
Li
David
D
Wong
Sookja K
SK
Chung
Amy C Y
AC
Lo
D000449:Aldehyde Reductase / Q000172:deficiency*; D000818:Animals; D000831:Animals, Newborn; D064032:Calbindin 2 / Q000378:metabolism; D064026:Calbindins / Q000378:metabolism; D004195:Disease Models, Animal; D004596:Electroretinography; D005904:Glial Fibrillary Acidic Protein; D005911:Gliosis / Q000201:enzymology / Q000517:prevention & control*; D007150:Immunohistochemistry; D051379:Mice; D009419:Nerve Tissue Proteins / Q000378:metabolism; D051571:Protein Kinase C-alpha / Q000378:metabolism; D012160:Retina / Q000503:physiopathology; D055351:Retinal Neurons / Q000201:enzymology*; D012178:Retinopathy of Prematurity / Q000201:enzymology / Q000517:prevention & control*; D014404:Tubulin / Q000378:metabolism
C576511:Calb2 protein, mouse; D064032:Calbindin 2; D064026:Calbindins; D005904:Glial Fibrillary Acidic Protein; D009419:Nerve Tissue Proteins; D014404:Tubulin; C462941:beta3 tubulin, mouse; C528900:glial fibrillary astrocytic protein, mouse; D000449:Aldehyde Reductase; D051571:Protein Kinase C-alpha